These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 27717378)
1. Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer. Steitz J; Naumann P; Ulrich S; Haefner MF; Sterzing F; Oelfke U; Bangert M Radiat Oncol; 2016 Oct; 11(1):134. PubMed ID: 27717378 [TBL] [Abstract][Full Text] [Related]
2. Probabilistic dose distribution from interfractional motion in carbon ion radiation therapy for prostate cancer shows rectum sparing with moderate target coverage degradation. Bridges D; Kawamura H; Kanai T PLoS One; 2018; 13(8):e0203289. PubMed ID: 30169520 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of Single Field Multi-Ion Particle Therapy Treatments. Kopp B; Mein S; Dokic I; Harrabi S; Böhlen TT; Haberer T; Debus J; Abdollahi A; Mairani A Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):194-205. PubMed ID: 31610250 [TBL] [Abstract][Full Text] [Related]
4. Comparing the dosimetric impact of interfractional anatomical changes in photon, proton and carbon ion radiotherapy for pancreatic cancer patients. Houweling AC; Crama K; Visser J; Fukata K; Rasch CR; Ohno T; Bel A; van der Horst A Phys Med Biol; 2017 Apr; 62(8):3051-3064. PubMed ID: 28252445 [TBL] [Abstract][Full Text] [Related]
5. EUD-based biological optimization for carbon ion therapy. Brüningk SC; Kamp F; Wilkens JJ Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717 [TBL] [Abstract][Full Text] [Related]
6. Dosimetric considerations to determine the optimal technique for localized prostate cancer among external photon, proton, or carbon-ion therapy and high-dose-rate or low-dose-rate brachytherapy. Georg D; Hopfgartner J; Gòra J; Kuess P; Kragl G; Berger D; Hegazy N; Goldner G; Georg P Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):715-22. PubMed ID: 24521685 [TBL] [Abstract][Full Text] [Related]
7. Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer. Dreher C; Habermehl D; Ecker S; Brons S; El-Shafie R; Jäkel O; Debus J; Combs SE Radiat Oncol; 2015 Nov; 10():237. PubMed ID: 26590103 [TBL] [Abstract][Full Text] [Related]
8. Optimizing 3DCT image registration for interfractional changes in carbon-ion prostate radiotherapy. Hirai R; Mori S; Suyari H; Tsuji H; Ishikawa H Sci Rep; 2023 May; 13(1):7448. PubMed ID: 37156901 [TBL] [Abstract][Full Text] [Related]
9. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy. Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546 [TBL] [Abstract][Full Text] [Related]
10. Spot-scanning hadron arc (SHArc) therapy: A proof of concept using single- and multi-ion strategies with helium, carbon, oxygen, and neon ions. Mein S; Kopp B; Tessonnier T; Liermann J; Abdollahi A; Debus J; Haberer T; Mairani A Med Phys; 2022 Sep; 49(9):6082-6097. PubMed ID: 35717613 [TBL] [Abstract][Full Text] [Related]
11. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC). Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885 [TBL] [Abstract][Full Text] [Related]
12. Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma. Bennan ABA; Unkelbach J; Wahl N; Salome P; Bangert M Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):559-572. PubMed ID: 34058258 [TBL] [Abstract][Full Text] [Related]
13. A Monte Carlo-based treatment-planning tool for ion beam therapy. Böhlen TT; Bauer J; Dosanjh M; Ferrari A; Haberer T; Parodi K; Patera V; Mairani A J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i77-81. PubMed ID: 23824131 [TBL] [Abstract][Full Text] [Related]
15. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy. Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724 [TBL] [Abstract][Full Text] [Related]
16. Robust treatment planning with 4D intensity modulated carbon ion therapy for multiple targets in stage IV non-small cell lung cancer. Wolf M; Anderle K; Durante M; Graeff C Phys Med Biol; 2020 Nov; 65(21):215012. PubMed ID: 32610300 [TBL] [Abstract][Full Text] [Related]
17. Biological Dose Optimization for Particle Arc Therapy Using Helium and Carbon Ions. Mein S; Tessonnier T; Kopp B; Schömers C; Harrabi S; Abdollahi A; Debus J; Haberer T; Mairani A Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):334-348. PubMed ID: 35490991 [TBL] [Abstract][Full Text] [Related]
18. Robustness of 4D-optimized scanned carbon ion beam therapy against interfractional changes in lung cancer. Graeff C Radiother Oncol; 2017 Mar; 122(3):387-392. PubMed ID: 28073579 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous optimization of RBE-weighted dose and nanometric ionization distributions in treatment planning with carbon ions. Burigo LN; Ramos-Méndez J; Bangert M; Schulte RW; Faddegon B Phys Med Biol; 2019 Jan; 64(1):015015. PubMed ID: 30523890 [TBL] [Abstract][Full Text] [Related]
20. Gated carbon-ion scanning treatment for pancreatic tumour with field specific target volume and organs at risk. Miki K; Mori S; Shiomi M; Yamada S Phys Med; 2016 Dec; 32(12):1521-1528. PubMed ID: 27884463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]